{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:31:23Z","timestamp":1716287483843},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"Supplement_A","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/eurheartj\/suy036","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:05:14Z","timestamp":1551179114000},"page":"A34-A40","source":"Crossref","is-referenced-by-count":3,"title":["New frontiers for management of hyperkalaemia: the emergence of novel agents"],"prefix":"10.1093","volume":"21","author":[{"given":"Michael E","family":"Nassif","sequence":"first","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri-Kansas City, 4401 Wornall Rd, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri-Kansas City, 4401 Wornall Rd, Kansas City, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"key\n\t\t\t\t2019022808505108600_suy036-B1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1313341","article-title":"An integrated view of potassium homeostasis","volume":"373","author":"Gumz","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/03007995.2018.1433141","article-title":"The prevalence of hyperkalemia in the United States","volume":"34","author":"Betts","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE.114.001104","article-title":"Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist","volume":"7","author":"Vardeny","year":"2014","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of Spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES","volume":"78","author":"Pitt","year":"1996","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","article-title":"Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B10","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2013\/502451","article-title":"Development of colonic perforation during calcium polystyrene sulfonate administration: a case report","volume":"2013","author":"Takeuchi","year":"2013","journal-title":"Case Rep Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0272-6386(12)80544-0","article-title":"Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol","volume":"20","author":"Gerstman","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B12","author":"Relypsa","year":"2016","journal-title":"Veltassa (Patiromer) for Oral Suspension [Package Insert]"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B13","first-page":"9","article-title":"Characterization of structure and function of SZC, a K+ selective ion trap","author":"Stavros","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1074248416629549","article-title":"Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia","volume":"21","author":"Li","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2050-6511-15-2","article-title":"A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects","volume":"15","author":"Henderson","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney dkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease the AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/phar.1906","article-title":"Systematic review and meta-analysis of patiromer and sodium zirconium cyclosilicate: a new armamentarium for the treatment of hyperkalemia","volume":"37","author":"Meaney","year":"2017","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, SZC, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the harmonize randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMc1500353","article-title":"Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia","volume":"372","author":"Kosiborod","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B25","year":"2017"},{"key":"key\n\t\t\t\t2019022808505108600_suy036-B26","year":"2017"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/21\/Supplement_A\/A34\/27994247\/suy036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T14:06:01Z","timestamp":1551362761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/21\/Supplement_A\/A34\/5364184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":26,"journal-issue":{"issue":"Supplement_A","published-online":{"date-parts":[[2019,2,26]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suy036","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2,1]]}}}